Pain Research: University of Arizona scientists report cannabis-derived terpenes may relieve chronic pain (including fibromyalgia and post-surgical pain) without THC-like intoxication, pointing to aroma compounds as potential safer therapies. Contamination Check: Arizona State University research on seized illicit cannabis found fentanyl was not detected in tested samples, while other drugs appeared only at low or trace levels—suggesting contamination is less common than feared, though not zero. Medical Cannabis for Connective-Tissue Disorders: A UK registry study in EDS/HSD patients found cannabis-based medicinal products linked to meaningful pain reductions and fewer opioid use over 24 months. Policy Impact (Global): A Lancet review says decriminalization or tightly controlled legalization doesn’t clearly raise overall cannabis use, but profit-driven commercial markets correlate with higher addiction and more psychiatric hospital admissions. Vaping Crackdown: Malaysia’s health minister cited 402 vape seizure cases involving synthetic drugs (including cannabinoids/THC) as a basis to move toward banning vapes. Regulated Cultivation (India): Himachal Pradesh approved regulated cannabis cultivation, framing industrial hemp/low-intoxicant medicinal cannabis as income for farmers and inputs for textiles, cosmetics, and pharma.